The Latest Cardiac and Vascular News
BASKING RIDGE, N.J., Sept. 27, 2018 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiovascular indications, announced today that management will participate at the following conferences in October: 2018 Cell & Gene Meeting on […]
CALGARY, Alberta, Sept. 27, 2018 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM) is pleased to announce that at the Annual and Special Meeting of Shareholders (the “Meeting”) held on September 26, 2018, shareholders overwhelmingly approved all the resolutions placed before the Meeting and as outlined […]
BURLINGTON, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it has acquired the vascular clot management business of Applied Medical Resources Corporation for $14.2 million, of which $11.0 million was paid at closing and $3.2 million will be paid in two post-closing installments. As […]
TEL AVIV, Israel, Sept. 27, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that preliminary cumulative three-year follow-up safety, efficacy and stroke prevention durability data from […]
NEW YORK, Sept. 27, 2018 /PRNewswire/ — TARA Biosystems Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and development applications, announced today the launch of Cardiotype.Fo, the best-in-class in vitrosystem for assessment of cardiac contractility. Contractility of heart muscle tissue is a critically important measure of cardiac function and is used routinely […]
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the first quarter of fiscal year 2019, which ended August 31, 2018. “Our operating and financial accomplishments during the first quarter reflect our ongoing commitment to building […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED) today announced the pricing of its initial public offering of 3,900,000 shares of common stock at a price to the public of $17.00 per share. In addition, Ra Medical has granted the underwriters a 30-day option to purchase up to an additional […]
IRVINE, CALIFORNIA – September 27, 2018 — Inari Medical, Inc. announced today the enrollment of the first patient in the ClotTriever Outcomes Registry (“CLOUT”) using the ClotTriever® Thrombectomy System. CLOUT is a 500-patient prospective, multicenter, single-arm registry to evaluate real world outcomes after treatment of patients with thrombosis in the […]
Highlights: • Osprey Medical showcased at the 30th Transcatheter Cardiovascular Therapeutics (TCT) conference with two scientific sessions and moderated abstract sessions focused on awareness and prevention of contrast induced Acute Kidney Injury (AKI) • Osprey Medical featured its Be Kind to Kidneys Program, patient education materials and GE partnership at […]
SEATTLE, Sept. 26, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced it was selected as one of six winners of the […]
